80 related articles for article (PubMed ID: 9099163)
21. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
Ammar H; Malani AK; Gupta C
BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
[No Abstract] [Full Text] [Related]
22. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
Granados Loarca EA
Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
[TBL] [Abstract][Full Text] [Related]
23. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
[No Abstract] [Full Text] [Related]
24. Advances in the medical management of benign prostatic hyperplasia.
Jewett MA; Klotz LH;
CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985
[No Abstract] [Full Text] [Related]
25. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
[No Abstract] [Full Text] [Related]
26. Benign prostatic hyperplasia (BPH).
Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
[No Abstract] [Full Text] [Related]
27. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
Loran OB; Pushkar' DIu; Rasner PI
Urologiia; 2002; (1):19-22. PubMed ID: 11877966
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Foley SJ; Soloman LZ; Wedderburn AW; Kashif KM; Summerton D; Basketter V; Holmes SA
J Urol; 2000 Feb; 163(2):496-8. PubMed ID: 10647664
[TBL] [Abstract][Full Text] [Related]
29. Current management and future trends in benign prostatic hyperplasia (BPH).
Fitzpatrick JM
Ir Med J; 1997 Nov; 90(7):256, 258. PubMed ID: 10036815
[No Abstract] [Full Text] [Related]
30. [New agents developed for the treatment of benign prostatic hyperplasia].
Akakura K
Nihon Rinsho; 2002 Dec; 60 Suppl 11():373-7. PubMed ID: 12599603
[No Abstract] [Full Text] [Related]
31. Benign prostatic hypertrophy.
Geller J
Curr Ther Endocrinol Metab; 1997; 6():586-93. PubMed ID: 9174812
[No Abstract] [Full Text] [Related]
32. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of prostatic adenoma patients with inhibitor of 5-alpha-reductase of type I and II avodart (dutasteride)].
Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
Urologiia; 2006; (6):83-6. PubMed ID: 17315721
[No Abstract] [Full Text] [Related]
34. Finasteride revisited: Proscar for the prostate and Propecia for the pate.
Harv Mens Health Watch; 2000 Jul; 4(12):1-4. PubMed ID: 10877872
[No Abstract] [Full Text] [Related]
35. Managing benign prostatic hyperplasia.
Garnett S; Abrams P
Practitioner; 2001 Oct; 245(1627):830-2, 834, 836 passim. PubMed ID: 11677898
[No Abstract] [Full Text] [Related]
36. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
[TBL] [Abstract][Full Text] [Related]
37. Re: A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Harrison RH
J Urol; 2000 Nov; 164(5):1670-1. PubMed ID: 11203073
[No Abstract] [Full Text] [Related]
38. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
[TBL] [Abstract][Full Text] [Related]
39. Drug treatment for benign prostatic hyperplasia. Health authorities must audit use of finasteride.
Mendelsohn R; Thompson D
BMJ; 1997 Aug; 315(7104):370-1. PubMed ID: 9270473
[No Abstract] [Full Text] [Related]
40. Treatment of benign prostatic hyperplasia. The Scandinavian BPH Study Group.
Andersen JT
Lancet; 1996 May; 347(9010):1270. PubMed ID: 8622491
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
